Literature DB >> 29674758

Evaluation of the Upper Gastrointestinal Tract in Ulcerative Colitis Patients.

Ryo Kato1, Masaya Iwamuro, Sakiko Hiraoka, Shiho Takashima, Toshihiro Inokuchi, Masahiro Takahara, Yoshitaka Kondo, Takehiro Tanaka, Hiroyuki Okada.   

Abstract

To analyze the clinical characteristics of patients with ulcerative colitis who have upper gastrointestinal lesions, we retrospectively reviewed the data of 216 patients with ulcerative colitis who underwent esophagogastroduodenoscopy at our institute in April 2008-March 2016. We investigated the endoscopic features and compared the clinical characteristics between the patients with and without upper gastrointestinal lesions. Forty-two patients (19.4%) had upper gastrointestinal lesions, including multiple erosions (n=18), bamboo joint-like appearance (n=17), mucosa with white spots (n=4), friable mucosa (n=2), ulcer (n=1), and purulent deposits within the mucosa (n=1) in the stomach and/or duodenum. Compared to the patients without upper gastrointestinal lesions, those with upper gastrointestinal lesions showed significantly more frequent extraintestinal manifestations (19.0% vs. 8.0%, p<0.05) and a significant history of colectomy (33.3% vs. 12.1%, p<0.01). There were no significant differences with regard to the sex ratio, age at esophagogastroduodenoscopy, gastrointestinal symptoms, time since the diagnosis of ulcerative colitis, type of colitis at the initial diagnosis of ulcerative colitis, or gastric atrophy between the groups. In conclusion, gastroduodenal lesions were identified in 19.4% of the patients with ulcerative colitis. Esophagogastroduodenoscopy is particularly recommended for ulcerative colitis patients who show extraintestinal manifestations and for those who have undergone a colectomy.

Entities:  

Keywords:  esophagogastroduodenoscopy; gastritis; ulcerative colitis

Mesh:

Year:  2018        PMID: 29674758     DOI: 10.18926/AMO/55850

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  4 in total

1.  Severe immune checkpoint inhibitor-associated gastritis: A case series and literature review.

Authors:  Yuya Sugiyama; Hiroki Tanabe; Taisuke Matsuya; Yu Kobayashi; Yuki Murakami; Takahiro Sasaki; Takehito Kunogi; Keitaro Takahashi; Katsuyoshi Ando; Nobuhiro Ueno; Shin Kashima; Kentaro Moriichi; Mishie Tanino; Yusuke Mizukami; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Endosc Int Open       Date:  2022-07-15

2.  Ulcerative colitis with mucosal lesions in duodenum: Two case reports.

Authors:  Muran Li; Yandi Liu; Jifang Cui; Hai Qin; Yang Shi; Shiwu Zhang; Yongjie Zhao
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 3.  Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review.

Authors:  Yan Sun; Zhe Zhang; Chang-Qing Zheng; Li-Xuan Sang
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

4.  Gastroduodenitis associated with ulcerative colitis: A case report.

Authors:  Ye Yang; Chun-Qiang Li; Wu-Jie Chen; Zhen-Hua Ma; Gang Liu
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.